Citizens Maintains Market Outperform on LeonaBio, Lowers Price Target to $17

LeonaBio, Inc.

LeonaBio, Inc.

LONA

0.00

Citizens analyst Jason N. Butler maintains LeonaBio (NASDAQ: LONA) with a Market Outperform and lowers the price target from $18 to $17.